Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by Candyswanwickon Mar 28, 2017 2:04am
218 Views
Post# 26038905

RE:RE:RE:Adrift...

RE:RE:RE:Adrift...
PoorOpinion wrote: I'll go back to something I said a while back. The only place that expects immediate, large, transformative deals is this bullboard. Its not a key part of managements strategy and as far as I'm aware its never been promised by management. If you're waiting for that transformative deal then I believe you've allowed yourself to be influenced by mis-guided opinion here. A big deal may come, it may not, but tHe companies future does not rely on a transformative deal soon, if your investment strategy does then I suggest you try to weigh the expectation of that here with what GUD has been saying about its strategy and maybe make the appropriate adjustment. Just my opinion.

As for the SP. I remember it being suggested that at 10-11$ the SP had got slightly ahead of itself so a bit of a pause around this price is not unexpected, I been making small purchases this year when it was in the low tens or dipped below. My hope is that in 12 months and beyond that looks like a gud deal. I'm not sweating the next few months.

altior wrote: Fully agree. Sitting at 10 bucks is no fun. Some deals would be welcome. Hope the possibilities
will show up soon enough. Hope is no substitute for real deals. So possibilities should be incarnated in deals. The recent past was rather disappointing. The future is ahead, and waiting is no fun. For the time being, it is just the waiting going on. Something must occur, anything really....



This bullboard is still so much better than most...
Bullboard Posts